Search research articles
Contact Us
Filters
Showing results (171-180 of 182) with videos related to
Page
of 19
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
July 9, 2014
Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection
Pappanaicken R Kumaresan, Pallavi R Manuri, Nathaniel D Albert, et al.
Diabetologia
|
December 14, 2011
Increased metabolic rate and insulin sensitivity in male mice lacking the carcino-embryonic antigen-related cell adhesion molecule 2
P R Patel, S K Ramakrishnan, M K Kaw, et al.
Metabolism: Clinical and Experimental
|
April 23, 2023
Loss of CEACAM1 in endothelial cells causes hepatic fibrosis
Harrison T Muturi, Hilda E Ghadieh, Raziyeh Abdolahipour, et al.
The Journal of Biological Chemistry
|
November 21, 2015
Increased Glucose-induced Secretion of Glucagon-like Peptide-1 in Mice Lacking the Carcinoembryonic Antigen-related Cell Adhesion Molecule 2 (CEACAM2)
Simona S Ghanem, Garrett Heinrich, Sumona G Lester, et al.
Cell Metabolism
|
April 7, 2021
Voices: Insulin and beyond
Jesse Roth, Frances M Ashcroft, Claes B Wollheim, et al.
Diabetes
|
May 15, 2015
Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance
Qusai Y Al-Share, Anthony M DeAngelis, Sumona Ghosh Lester, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
June 27, 2013
Ceacam1 deletion causes vascular alterations in large vessels
Sonia M Najjar, Kelly J Ledford, Simon L Abdallah, et al.
Nature Communications
|
July 17, 2023
Restoration of PITPNA in Type 2 diabetic human islets reverses pancreatic beta-cell dysfunction
Yu-Te Yeh, Chandan Sona, Xin Yan, et al.
Molecular Metabolism
|
August 21, 2024
Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation
Harrison T Muturi, Hilda E Ghadieh, Suman Asalla, et al.
Journal for Immunotherapy of Cancer
|
May 22, 2021
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma
Chantal Saberian, Rodabe N Amaria, Amer M Najjar, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 182) with videos related to
Sort By:
Page
of 19
Proceedings of the National Academy of Sciences of the United States of America
|
July 9, 2014
Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection
Pappanaicken R Kumaresan, Pallavi R Manuri, Nathaniel D Albert, et al.
Diabetologia
|
December 14, 2011
Increased metabolic rate and insulin sensitivity in male mice lacking the carcino-embryonic antigen-related cell adhesion molecule 2
P R Patel, S K Ramakrishnan, M K Kaw, et al.
Metabolism: Clinical and Experimental
|
April 23, 2023
Loss of CEACAM1 in endothelial cells causes hepatic fibrosis
Harrison T Muturi, Hilda E Ghadieh, Raziyeh Abdolahipour, et al.
The Journal of Biological Chemistry
|
November 21, 2015
Increased Glucose-induced Secretion of Glucagon-like Peptide-1 in Mice Lacking the Carcinoembryonic Antigen-related Cell Adhesion Molecule 2 (CEACAM2)
Simona S Ghanem, Garrett Heinrich, Sumona G Lester, et al.
Cell Metabolism
|
April 7, 2021
Voices: Insulin and beyond
Jesse Roth, Frances M Ashcroft, Claes B Wollheim, et al.
Diabetes
|
May 15, 2015
Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance
Qusai Y Al-Share, Anthony M DeAngelis, Sumona Ghosh Lester, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
June 27, 2013
Ceacam1 deletion causes vascular alterations in large vessels
Sonia M Najjar, Kelly J Ledford, Simon L Abdallah, et al.
Nature Communications
|
July 17, 2023
Restoration of PITPNA in Type 2 diabetic human islets reverses pancreatic beta-cell dysfunction
Yu-Te Yeh, Chandan Sona, Xin Yan, et al.
Molecular Metabolism
|
August 21, 2024
Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation
Harrison T Muturi, Hilda E Ghadieh, Suman Asalla, et al.
Journal for Immunotherapy of Cancer
|
May 22, 2021
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma
Chantal Saberian, Rodabe N Amaria, Amer M Najjar, et al.
Page
of 19